First Trust Direct Indexing’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,213
Closed -$235K 105
2024
Q3
$235K Sell
1,213
-1,533
-56% -$321K 0.01% 851
2024
Q2
$637K Buy
2,746
+1,006
+58% +$219K 0.04% 437
2024
Q1
$375K Sell
1,740
-101
-5% -$23.7K 0.03% 553
2023
Q4
$476K Buy
1,841
+167
+10% +$41K 0.04% 453
2023
Q3
$430K Sell
1,674
-250
-13% -$66.9K 0.05% 431
2023
Q2
$548K Buy
1,924
+146
+8% +$43.5K 0.06% 387
2023
Q1
$494K Buy
1,778
+18
+1% +$4.98K 0.06% 402
2022
Q4
$487K Buy
1,760
+388
+28% +$110K 0.06% 389
2022
Q3
$366K Buy
1,372
+114
+9% +$24.2K 0.05% 418
2022
Q2
$257K Buy
1,258
+31
+3% +$6.34K 0.04% 519
2022
Q1
$258K Buy
1,227
+100
+9% +$21.7K 0.03% 548
2021
Q4
$270K Sell
1,127
-119
-10% -$30.6K 0.04% 521
2021
Q3
$353K Buy
1,246
+200
+19% +$65.5K 0.05% 432
2021
Q2
$362K Sell
1,046
-464
-31% -$141K 0.05% 416
2021
Q1
$422K Buy
1,510
+126
+9% +$34K 0.11% 249
2020
Q4
$339K Buy
+1,384
New +$357K 0.09% 272

Other funds holding BIIB